PubRank

Fulvio Morello

Author PubWeight™ 38.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005 7.66
2 Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006 5.93
3 Therapeutic potential of endothelial progenitor cells in cardiovascular diseases. Hypertension 2005 2.03
4 Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study. Crit Care 2013 1.55
5 Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110γ. Mol Cell 2011 1.52
6 Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells 2009 1.50
7 Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 2002 1.23
8 Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury. Proc Natl Acad Sci U S A 2004 1.09
9 Essential role of the p110beta subunit of phosphoinositide 3-OH kinase in male fertility. Mol Biol Cell 2010 1.07
10 Twice upon a time: PI3K's secret double life exposed. Trends Biochem Sci 2009 0.98
11 Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro. Hypertension 2010 0.94
12 Antihypertensive drugs and the sympathetic nervous system. J Cardiovasc Pharmacol 2007 0.94
13 Diagnosis and treatment of low-renin hypertension. Clin Endocrinol (Oxf) 2007 0.91
14 Phosphoinositide 3-kinase γ protects against catecholamine-induced ventricular arrhythmia through protein kinase A-mediated regulation of distinct phosphodiesterases. Circulation 2012 0.91
15 Mesenchymal stem cells differentiate into renin-producing juxtaglomerular (JG)-like cells under the control of liver X receptor-alpha. J Biol Chem 2010 0.88
16 Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2. Arterioscler Thromb Vasc Biol 2012 0.86
17 Myocyte signalling in leucocyte recruitment to the heart. Cardiovasc Res 2014 0.84
18 Rule out of acute aortic dissection with plasma matrix metalloproteinase 8 in the emergency department. Crit Care 2013 0.83
19 Baroreflex sensitivity correlates with left ventricular morphology and diastolic function in essential hypertension. J Hypertens 2007 0.83
20 Early cardiovascular autonomic dysfunction, beta cell function and insulin resistance in obese adolescents. Acta Biomed 2009 0.82
21 Nuclear hormone receptors as regulators of the renin-angiotensin-aldosterone system. Hypertension 2008 0.80
22 Specific PI3K isoform modulation in heart failure: lessons from transgenic mice. Curr Heart Fail Rep 2011 0.78
23 Phosphoinositide 3-kinases in health and disease. Subcell Biochem 2012 0.78
24 Primary aldosteronism (PA) and endothelial progenitor cell (EPC) bioavailability. Clin Endocrinol (Oxf) 2008 0.77
25 May thrombopoietin be a useful marker of sepsis severity assessment in patients with SIRS entering the emergency department? Clin Chem Lab Med 2014 0.77
26 Therapeutic applications of PI3K inhibitors in cardiovascular diseases. Future Med Chem 2013 0.77
27 Genetics of primary aldosteronism. J Hypertens 2004 0.76
28 Diagnostic performance of emergency transthoracic focus cardiac ultrasound in suspected acute type A aortic dissection. Intern Emerg Med 2014 0.76
29 Thrombopoietin as Early Biomarker of Disease Severity in Patients With Acute Pancreatitis. Pancreas 2017 0.75
30 Bleeding prevalence and transfusion requirement in patients with thrombocytopenia in the emergency department. Clin Chem Lab Med 2014 0.75
31 Aldosterone as an independent factor in cerebrovascular damage. Clin Exp Hypertens 2008 0.75